Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 3Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Toxemia 1Stomach Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Myocarditis 1Muscle Weakness 1Melanoma 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Diabetes, Gestational 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Neuroendocrine 1Carcinoma in Situ 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

dodecyl maltoside 2Magnetic Resonance Imaging 2Electrocardiography 2Diphenhydramine 2Acetaminophen 2fludarabine phosphate 1fludarabine 1durvalumab 1aldesleukin 1Tomography, X-Ray Computed 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Mastectomy, Subcutaneous 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Histamine Antagonists 1Granisetron 1Droperidol 1Doxylamine 1Docetaxel 1Diphenoxylate 1Cystoscopy 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma in Situ × Positron-Emission Tomography × 90 days × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡